Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A S Simbirtsev

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
European Cytokine Network|January 10, 2002
Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. I. Phase I-II clinical trials of recombinant human interleukin-1 beta as a leukopoiesis stimulator in cancer patients receiving combination chemotherapyM L Gershanovich, L V Filatova, S A Ketlinsky, et al.
Voprosy Onkologii|September 8, 2000
[The leuko-stimulating and protective action of human recombinant interleukin-1 beta (betaleukin) in the chemotherapy of malignant tumors]L V Filatova, M L Gershanovich, S A Ketlinskiĭ, et al.
Vestnik Otorinolaringologii|September 6, 2019
[Proinflammatory cytokine content in the saliva of children suffering from chronic tonsillitis]N V Boiko, I V Stagnieva, A S Kim, et al.
Terapevticheskii Arkhiv|January 1, 1993
[The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis]S A Ketlinskiĭ, T G Alekseeva, N D Perumov, et al.
Bulletin of Experimental Biology and Medicine|April 17, 2010
Effect of interleukin-1beta on functional activity of lymphoid structures in the gastrointestinal tract of rats during acute emotional stressE A Ivanova, S S Pertsov, E V Koplik, et al.
Problemy Tuberkuleza|January 1, 1996
[Production of tumor necrosis factor-alpha and interleukin-1 beta in patients with pulmonary tuberculosis in relation to the course of a process and immunological features]B E Knoring, A S Simbirtsev, I I Sakharova, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|January 5, 2002
[Interleukin-1beta and depressive states]O E Zubareva, O M Efremov, A S Simbirtsev, et al.
European Cytokine Network|January 10, 2002
Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. II. Phase II study of the protective effect of recombinant human interleukin-1 beta on myelodepression induced by chemotherapy in cancer patientsM L Gershanovich, L V Filatova, S A Ketlinsky, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|June 23, 2005
[The action of proinflammatory cytokines on formation of behavior during early postnatal ontogenesis]O E Zumareva, A P Eliseeva, A S Simbirtsev, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|September 28, 2012
[The influence of neonatal interleukin-1beta increase on the formation of adult rats' spatial memory]A N Trofimov, O E Zubareva, A S Simbirtsev, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
European Cytokine Network|January 10, 2002
Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. I. Phase I-II clinical trials of recombinant human interleukin-1 beta as a leukopoiesis stimulator in cancer patients receiving combination chemotherapyM L Gershanovich, L V Filatova, S A Ketlinsky, et al.
Voprosy Onkologii|September 8, 2000
[The leuko-stimulating and protective action of human recombinant interleukin-1 beta (betaleukin) in the chemotherapy of malignant tumors]L V Filatova, M L Gershanovich, S A Ketlinskiĭ, et al.
Vestnik Otorinolaringologii|September 6, 2019
[Proinflammatory cytokine content in the saliva of children suffering from chronic tonsillitis]N V Boiko, I V Stagnieva, A S Kim, et al.
Terapevticheskii Arkhiv|January 1, 1993
[The content of interleukin-1 beta in the blood serum of patients with systemic lupus erythematosus and rheumatoid arthritis]S A Ketlinskiĭ, T G Alekseeva, N D Perumov, et al.
Bulletin of Experimental Biology and Medicine|April 17, 2010
Effect of interleukin-1beta on functional activity of lymphoid structures in the gastrointestinal tract of rats during acute emotional stressE A Ivanova, S S Pertsov, E V Koplik, et al.
Problemy Tuberkuleza|January 1, 1996
[Production of tumor necrosis factor-alpha and interleukin-1 beta in patients with pulmonary tuberculosis in relation to the course of a process and immunological features]B E Knoring, A S Simbirtsev, I I Sakharova, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|January 5, 2002
[Interleukin-1beta and depressive states]O E Zubareva, O M Efremov, A S Simbirtsev, et al.
European Cytokine Network|January 10, 2002
Recombinant human interleukin-1 beta: new possibilities for the prophylaxis and correction of toxic myelodepression in patients with malignant tumors. II. Phase II study of the protective effect of recombinant human interleukin-1 beta on myelodepression induced by chemotherapy in cancer patientsM L Gershanovich, L V Filatova, S A Ketlinsky, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|June 23, 2005
[The action of proinflammatory cytokines on formation of behavior during early postnatal ontogenesis]O E Zumareva, A P Eliseeva, A S Simbirtsev, et al.
Rossiiskii Fiziologicheskii Zhurnal Imeni I.M. Sechenova|September 28, 2012
[The influence of neonatal interleukin-1beta increase on the formation of adult rats' spatial memory]A N Trofimov, O E Zubareva, A S Simbirtsev, et al.
Pageof 6